Target intelligence / Profile preview

Cerebral microcirculation

Molecular classification
Other (not a protein/gene/classic molecular drug target; encompasses vascular endothelium, pericytes, smooth muscle cells, astrocytes, and extracellular matrix involved in small brain vessel structure/function)
01

Overview

Cerebral microcirculation constitutes the smallest blood vessels in the brain—including arterioles, capillaries, and venules—that enable exchange of gases, nutrients, metabolic waste, and signaling molecules between the blood and neural tissue[4][5][7]. These vessels are essential for maintaining the brain’s high metabolic demands and ensuring neuronal and glial viability. The integrity and dynamic regulation of the cerebral microcirculation underpins critical functions such as the blood-brain barrier, neurovascular coupling, and homeostatic control. Dysfunction in the cerebral microcirculation is implicated in a range of CNS diseases, including ischemic stroke, Alzheimer’s disease, and other neurodegenerative processes, especially when endothelial or pericyte function is disturbed or blood flow becomes heterogeneous[4][6]. While not a specific molecular entity, the health of this vascular compartment is important both as a pathophysiological substrate and, in some contexts, as a system-level therapeutic target via modulation of the cells and molecular mediators residing within it.

Other names
brain microcirculationcerebral microvasculaturemicrovessels of the brainbrain capillary networkcerebral capillaries
02

Mechanism of action

not a single target; actions may include improving perfusion, reducing blood-brain barrier leakage, protecting endothelial function, or modulating specific vascular pathways

03

Biological functions

Oxygen and nutrient deliveryCarbon dioxide and waste removalBlood-brain barrier maintenanceRegulation of tissue perfusion and homeostasisControl of vascular permeabilityImmune surveillance and inflammation regulationMaintenance of neurovascular unit integrity
04

Disease associations

Neurodegenerative disease (Alzheimer's disease, etc.)Ischemic stroke and reperfusion injuryVascular dementiaCerebral small vessel diseaseInflammation
05

Safety considerations

brain edemahemorrhagesecondary injury
06

Interacting drugs

vasodilators

4 more in the full profile.

Beyond the preview

Go deeper on Cerebral microcirculation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cerebral microcirculation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call